Group 1: Momentum Investing Overview - Momentum investing involves following a stock's recent trend, with the strategy of buying high and selling higher, capitalizing on established price movements [1] - The Zacks Momentum Style Score helps define momentum characteristics, with Fresenius (FMS) currently holding a Momentum Style Score of B [2] - Style Scores complement the Zacks Rank system, which has a strong track record of outperforming the market, with FMS rated as 1 (Strong Buy) [3] Group 2: Performance Metrics of Fresenius - FMS shares have increased by 10.94% over the past week, while the Zacks Medical - Instruments industry remained flat [5] - Over the past month, FMS shares rose by 12.52%, outperforming the industry’s 3.33% [5] - In the last quarter, FMS shares increased by 19.94%, and over the past year, they gained 24.27%, compared to the S&P 500's -3.37% and 13.7% respectively [6] Group 3: Trading Volume and Earnings Outlook - The average 20-day trading volume for FMS is 473,584 shares, indicating a bullish sign if the stock is rising with above-average volume [7] - In the past two months, five earnings estimates for FMS have increased, raising the consensus estimate from $2.01 to $2.13 [9] - For the next fiscal year, five estimates have also moved upwards, with no downward revisions [9] Group 4: Conclusion - Given the positive performance metrics and earnings outlook, FMS is positioned as a 1 (Strong Buy) stock with a Momentum Score of B, making it a potential pick for near-term gains [11]

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for moment ...

Group 1: Momentum Investing Overview - Momentum investing involves following a stock's recent trend, with the aim of buying high and selling higher, capitalizing on established price movements [1] - The Zacks Momentum Style Score helps define momentum characteristics, with Curtiss-Wright (CW) currently holding a Momentum Style Score of A [2] - Style Scores complement the Zacks Rank, which has a strong track record of outperformance; CW has a Zacks Rank of 2 (Buy) [3] Group 2: Performance Metrics - CW shares have increased by 7.53% over the past week, outperforming the Zacks Aerospace - Defense Equipment industry, which rose by 0.82% [5] - Over the past month, CW's price change is 23.16%, compared to the industry's 8.54% [5] - In the last quarter, CW shares rose by 21.38%, and over the past year, they increased by 43.96%, while the S&P 500 moved -3.42% and 14.16%, respectively [6] Group 3: Trading Volume and Earnings Outlook - CW's average 20-day trading volume is 229,544 shares, indicating a bullish sign when combined with rising stock prices [7] - In the past two months, four earnings estimates for CW have increased, with no downward revisions, raising the consensus estimate from $12.20 to $12.55 [9] - For the next fiscal year, four estimates have also moved upwards, with no downward revisions during the same period [9] Group 4: Conclusion - Given the strong performance metrics and positive earnings outlook, CW is positioned as a 2 (Buy) stock with a Momentum Score of A, making it a promising near-term investment [11]

Group 1: Momentum Investing Overview - Momentum investing involves following a stock's recent trend, with the aim of buying high and selling higher, capitalizing on established price movements [1] - The Zacks Momentum Style Score helps investors identify which metrics to focus on for momentum, addressing the challenges in defining momentum [2] Group 2: Si-Bone (SIBN) Performance - Si-Bone currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy), indicating strong potential for outperformance [3][4] - Over the past week, SIBN shares have increased by 32.17%, while the Zacks Medical - Instruments industry remained flat [6] - In a longer timeframe, SIBN shares have risen 14.58% over the past quarter and 25.2% over the past year, outperforming the S&P 500 which moved -3.09% and 13.39% respectively [7] Group 3: Trading Volume and Earnings Outlook - SIBN's average 20-day trading volume is 478,841 shares, which is a useful indicator of market interest and price movement [8] - In the past two months, 5 earnings estimates for SIBN have increased, raising the consensus estimate from -$0.67 to -$0.62 [10] - For the next fiscal year, 3 estimates have moved upwards while 1 has been revised downwards, indicating a positive trend in earnings outlook [10] Group 4: Conclusion - Considering the performance metrics and earnings outlook, SIBN is positioned as a promising momentum stock with a Momentum Score of B [12]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Huron Consulting (HURN) - Huron Consulting currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] Performance Metrics - HURN shares have increased by 9.86% over the past week, outperforming the Zacks Consulting Services industry, which rose by 1.97% [5] - Over the last quarter, HURN shares rose by 17.05%, and over the past year, they have surged by 71.84%, while the S&P 500 experienced declines of -5.82% and gains of 9.94%, respectively [6] - The average 20-day trading volume for HURN is 236,109 shares, indicating a bullish trend when combined with rising stock prices [7] Earnings Outlook - In the past two months, three earnings estimates for HURN have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $7.15 to $7.39 [9] - For the next fiscal year, three estimates have also moved higher, reflecting positive sentiment regarding the company's earnings potential [9] Conclusion - Given the strong performance metrics and positive earnings outlook, HURN is identified as a solid momentum pick and is recommended for consideration in the near term [11]